[1]
Brandi, H. , Schneider, S. and Ryttig, L. 2024. Incremental Risk of Adverse Events with Oral Janus Kinase Inhibitor Use in Atopic Dermatitis and Other Indications: A Systematic Review and Meta-Analysis. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s320. DOI:https://doi.org/10.25251/skin.8.supp.320.